Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA

Delayed Quote. Delayed  - 07/29 10:14:59 pm
9.51 USD   +0.42%
07/28 ARIAD PHARMACEU : beats 2Q profit forecasts
07/28 ARIAD PHARMACEU : Reports Second Quarter and First Half 2016 Financi..
07/07 ARIAD PHARMACEU : Biotechnology Equities Under the Scanner - Exelixi..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/25/2016 07/26/2016 07/27/2016 07/28/2016 07/29/2016 Date
8.2(c) 8.26(c) 8.42(c) 9.47(c) 9.51(c) Last
5 554 455 7 267 738 4 321 285 16 730 558 15 818 894 Volume
+1.11% +0.73% +1.94% +12.47% +0.42% Change
More quotes
Financials ($)
Sales 2016 193 M
EBIT 2016 -119 M
Net income 2016 -131 M
Debt 2016 224 M
Yield 2016 -
Sales 2017 244 M
EBIT 2017 -70,2 M
Net income 2017 -95,3 M
Debt 2017 240 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 10,5x
EV / Sales2017 8,42x
Capitalization 1 813 M
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products include Iclusig and Caregivers.The company was founded by Harvey J. Berger in April 1991 and is... 
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARIAD PHARMACEUTICALS, INC
07/28 ARIAD PHARMACEUTICALS : beats 2Q profit forecasts
07/28 ARIAD PHARMACEUTICALS INC : Results of Operations and Financial Condition, Regul..
07/28 ARIAD PHARMACEUTICALS : Reports Second Quarter and First Half 2016 Financial Res..
07/22 ARIAD PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders,..
07/07 ARIAD PHARMACEUTICALS : Announces Webcast of Its Annual Stockholders Meeting
07/07 ARIAD PHARMACEUTICALS : Biotechnology Equities Under the Scanner - Exelixis, Nov..
07/05 ARIAD PHARMACEUTICALS : to Webcast Conference Call on Second Quarter 2016 Financ..
06/30 ARIAD PHARMACEUTICALS : Announces Distribution Agreements for Iclusig® in Latin ..
06/30 ARIAD PHARMACEUTICALS : Initiates Submission of New Drug Application for Brigati..
06/24 ARIAD PHARMACEUTICALS : Announces Webcast of Its Annual Stockholders Meeting
More news
Sector news : Bio Therapeutic Drugs
07/29DJMerck Revenue Rises on Cancer, Hepatitis Treatments
07/29DJMERCK : Revenue Rises on Cancer, Hepatitis Treatments
07/29DJSanofi Profit Down as Diabetes Drug Sales Slip
07/28DJCELGENE : Lifts Guidance as Revlimid Sales Rise -- Update
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
07/29 BIOTECH FORUM DAILY DIGEST : Biotech Tries To Break Through Upward Resistance Le..
07/29 What Should Ariad Shareholders Watch For Heading Towards The End Of The Year?
07/28 ARIAD Pharmaceuticals' (ARIA) CEO Paris Panayiotopoulos on Q2 2016 Results - ..
07/28 ARIAD Pharmaceuticals revenues up 133% in Q2
07/28 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
Advertisement
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Technical analysis trends ARIAD PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 9,63 $
Spread / Average Target 1,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Paris Panayiotopoulos President, Chief Executive Officer & Director
Alexander John Denner Chairman
Manmeet Singh Soni Chief Financial Officer, Treasurer & Executive VP
Timothy P. Clackson Chief Scientific Officer
Frank G. Haluska Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ARIAD PHARMACEUTICALS,..51.52%1 813
AMGEN, INC.5.51%128 668
GILEAD SCIENCES, INC.-19.72%108 197
CELGENE CORPORATION-7.10%86 182
REGENERON PHARMACEUTIC..-24.28%43 192
VERTEX PHARMACEUTICALS..-23.54%23 798
More Results